HIV

Showing 1-10 of 16

This issue profiles a novel genetic approach to target pancreatic cancer tumor and regrowth, a study to identity genetic receptor changes related to HIV treatment, a study to identity gene types responsible for varying sleep patterns.

USD 250.00

USD 187.50 save 25 %

This issue profiles an innovative cell-free DNA blood test to detect Down syndrome, a novel experimental vaccine for Ebola, and a novel antibody therapy to reduce HIV loads.

USD 250.00

USD 187.50 save 25 %

03 Jul 2014  |  Global

A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS

Antiretroviral Combinations Continue to Transform the Treatment Landscape

This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...

USD 3,950.00

USD 2,962.50 save 25 %

26 Mar 2013  |  Global

Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS

Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens

This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...

USD 1,500.00

USD 1,125.00 save 25 %

23 Jan 2013  |  North America

Analysis of the European HIV Drugs Market

Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This res...

USD 4,950.00

USD 3,712.50 save 25 %

07 Dec 2012  |  Europe

Analysis of European HIV Diagnostics Market

Increasing Adoption of HIV Nucleic Acid Testing (NAT) and Automation Spurs Market Growth.

The increase in HIV awareness among people has led to the demand for effective diagnostic products and solutions. As a result, some new products based on NAT technology and non-NAT technology platforms are being developed. This research service analyses the HIV diagnostics market in Europe, particularly, HIV NAT diagnostics and HIV Immunodiagnostic...

USD 4,950.00

USD 3,712.50 save 25 %

This research service provides the latest trends in HIV molecular diagnostics and discusses the prospects of future developments in this segment.

USD 4,950.00

USD 3,712.50 save 25 %

This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview of the market in these regions together with market drivers,restraints and challenges in the whole Europe. Together it recommends strategies for the players in these market...

USD 4,950.00

USD 3,712.50 save 25 %

18 Apr 2009  |  Europe

European HIV/AIDS Therapeutics Markets

 

This research service analyses the rapidly evolving European HIV/AIDS therapeutic market. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the ...

USD 4,950.00

USD 3,712.50 save 25 %

This research service discusses technology developments in the HIV drugs sector.

USD 4,950.00

USD 3,712.50 save 25 %

Showing 1-10 of 16